Viewing nowCombinationXoneal Tablet 5/80/10 mg
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.

MFDS item code 201902301 · Approved 2019.04.15 · Insurance code 640007370
Treatment of hypertension, improvement of dyslipidemia, inhibition of atherosclerosis progression, and reduction of cardiovascular disease risk
This drug is used for patients with essential hypertension whose blood pressure is not adequately controlled even when treated with a combination of amlodipine and losartan. The rosuvastatin component is used as an adjunct to dietary therapy in patients with hyperlipidemia (including familial hypercholesterolemia) and dyslipidemia. It is also beneficial for patients with homozygous familial hypercholesterolemia and primary dysbetalipoproteinemia, helping to slow the progression of atherosclerosis in patients with hyperlipidemia. In particular, it is used to lower the risk of cardiovascular diseases, stroke, myocardial infarction, and arterial revascularization surgeries in high-risk patients with elevated high-sensitivity C-reactive protein levels. In summary, this drug effectively improves cardiovascular risks associated with hypertension and various dyslipidemias.
Take 1 tablet of this medicine once daily with water. It is recommended, if possible, to take it at the same time each day (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. Patients taking an amlodipine/valsartan combination and rosuvastatin as separate medicines may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted before starting the amlodipine/valsartan combination; however, a direct switch to the amlodipine/valsartan combination may be considered when blood pressure is not adequately controlled with monotherapy with either component, as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. ▷ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of rosuvastatin is contraindicated in some of these patients.
This drug can cause severe harm to the fetus and newborn when used during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Women who are pregnant or could become pregnant, as well as nursing mothers, should not use this drug. Patients with severe impairment of liver or kidney function should also refrain from taking this medication. Caution is needed for diabetic patients or those with moderate to severe renal impairment when used in conjunction with specific components. Patients with a history of muscle-related diseases or angioedema should also avoid taking this drug. Patients who are depleted of sodium or fluid should improve their condition prior to taking the drug and closely monitor blood pressure and symptoms during treatment. Blood potassium levels need to be frequently checked for patients with high potassium levels or those taking drugs that may increase potassium. Renal transplant patients or those with renal artery stenosis should carefully monitor kidney function during the use of this drug. Patients with heart failure or after myocardial infarction require careful monitoring, including assessments of renal function. This drug can be used in the elderly; however, particularly in those aged 75 and older, starting with a lower dose and gradually increasing is advisable. Caution is advised when driving or operating machinery as dizziness or fatigue may occur. Some of this drug's components may burden the liver and kidneys, thus regular tests of liver and kidney function are recommended. Additionally, if symptoms such as muscle pain or weakness occur, the patient should inform their doctor immediately, and blood tests may be required to check for muscle damage. As interactions with other medications may occur, it is essential to inform healthcare providers about any other drugs being taken. This drug contains certain dye components, so patients with allergies to these should exercise caution. Pregnant or nursing women should refrain from taking this drug, and women planning to become pregnant should use appropriate contraceptive methods. Safety and effectiveness have not been established for children, so it is not recommended. In cases of overdose, severe hypotension, shock, etc. can occur, necessitating immediate emergency treatment, while dosage adjustment and monitoring remain vital.
Peripheral edema, heat sensation, increased ALT, increased AST, increased serum creatinine, flank pain, neck pain, dizziness, sensory loss, nasopharyngitis, rash, nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, erythema, sweating, rash, itching, joint swelling, low back pain, arthritis, muscle cramps, lethargy, polyuria, diabetes, erectile dysfunction, edema, systemic edema, facial edema, fatigue, flushing, asthenia, facial flushing, chest pain, pain, nocturia, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, hypercholesterolemia, hypoglycemia, urticaria, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturia, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, serum sickness, increased serum potassium, vasculitis, increased liver function levels, angioedema, bullous dermatitis, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, polyneuropathy, memory loss, peripheral neuropathy, thrombocytopenia, jaundice, increased transaminases, eosinophilia, drug reaction with eosinophilia and systemic symptoms syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, insulin-dependent diabetes mellitus, diabetic complications, headache, dizziness, constipation, nausea, abdominal pain, itching, myopathy, rhabdomyolysis, asthenia, weight loss, weight gain, arthralgia, musculoskeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neurogenic hypersensitivity, sensory loss, Stevens-Johnson syndrome, increased serum creatinine, spinal stenosis, aphasia, oral bleeding, vomiting, increased blood glucose, increased triglycerides, hypercholesterolemia, increased blood pressure, exacerbation of hypertension, neck/shoulder pain, leg fractures, toe fractures, spinal fractures, fractures, osteomyelitis, skin infection, dermatitis unspecified, skin mass, local skin reaction, palpitations, second-degree AV block, worsening angina, hearing abnormalities, vestibulitis, overactive bladder, retinal detachment, vitreous detachment, skin tumor-like lesions unspecified, benign prostatic hyperplasia, herpes zoster, intervertebral disc herniation, laceration
Not everyone experiences these, and they can vary from person to person.
This drug should be kept in a tightly closed container to avoid exposure to air or moisture and should be stored at room temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the effectiveness of the medication for a longer period.
Pink oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Valsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharm Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.